Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryuzo Ueda

Showing results (251-260 of 333) with videos related to

Pageof 34
Sort By:
Carcinogenesis|March 27, 2004
Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer riskHidemi Ito, Keitaro Matsuo, Nobuyuki Hamajima, et al.
Cancer Immunology, Immunotherapy : CII|December 3, 2008
Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rgamma(null) mouse modelAsahi Ito, Takashi Ishida, Hiroki Yano, et al.
Nagoya Journal of Medical Science|December 17, 2021
Phase Ib study on the humanized anti-CCR4 antibody, KW-0761, in advanced solid tumorsTakuro Saito, Koji Kurose, Takashi Kojima, et al.
Journal of Medical Virology|June 22, 2006
Molecular epidemiology of hepatitis B virus in the United Republic of TanzaniaIzumi Hasegawa, Yasuhito Tanaka, Fuat Kurbanov, et al.
International Journal of Cancer|January 21, 2014
Over one-third of African-American MGUS and multiple myeloma patients are carriers of hyperphosphorylated paratarg-7, an autosomal dominantly inherited risk factor for MGUS/MMCarsten Zwick, Gerhard Held, Michaela Auth, et al.
Nagoya Journal of Medical Science|November 2, 2020
Identification of cisplatin-resistant factor by integration of transcriptomic and proteomic data using head and neck carcinoma cell linesDaisuke Inukai, Kunihiro Nishimura, Hiroki Okamoto, et al.
Cancer Immunology, Immunotherapy : CII|August 22, 2018
Increased Tim-3<sup>+</sup> T cells in PBMCs during nivolumab therapy correlate with responses and prognosis of advanced esophageal squamous cell carcinoma patientsRyo Kato, Makoto Yamasaki, Shinya Urakawa, et al.
Blood|February 11, 2012
Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphomaHiroyoshi Nishikawa, Yuka Maeda, Takashi Ishida, et al.
Journal of Medicinal Chemistry|November 3, 2012
Rapid discovery of highly potent and selective inhibitors of histone deacetylase 8 using click chemistry to generate candidate librariesTakayoshi Suzuki, Yosuke Ota, Masaki Ri, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 31, 2003
Further investigation of the epitope recognized by the new monoclonal antibody 2C9Keitaro Kato, Kazuhiro Yoshikawa, Tomohiro Taki, et al.
Pageof 34

Showing results (251-260 of 333) with videos related to

Sort By:
Pageof 34
Carcinogenesis|March 27, 2004
Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer riskHidemi Ito, Keitaro Matsuo, Nobuyuki Hamajima, et al.
Cancer Immunology, Immunotherapy : CII|December 3, 2008
Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rgamma(null) mouse modelAsahi Ito, Takashi Ishida, Hiroki Yano, et al.
Nagoya Journal of Medical Science|December 17, 2021
Phase Ib study on the humanized anti-CCR4 antibody, KW-0761, in advanced solid tumorsTakuro Saito, Koji Kurose, Takashi Kojima, et al.
Journal of Medical Virology|June 22, 2006
Molecular epidemiology of hepatitis B virus in the United Republic of TanzaniaIzumi Hasegawa, Yasuhito Tanaka, Fuat Kurbanov, et al.
International Journal of Cancer|January 21, 2014
Over one-third of African-American MGUS and multiple myeloma patients are carriers of hyperphosphorylated paratarg-7, an autosomal dominantly inherited risk factor for MGUS/MMCarsten Zwick, Gerhard Held, Michaela Auth, et al.
Nagoya Journal of Medical Science|November 2, 2020
Identification of cisplatin-resistant factor by integration of transcriptomic and proteomic data using head and neck carcinoma cell linesDaisuke Inukai, Kunihiro Nishimura, Hiroki Okamoto, et al.
Cancer Immunology, Immunotherapy : CII|August 22, 2018
Increased Tim-3<sup>+</sup> T cells in PBMCs during nivolumab therapy correlate with responses and prognosis of advanced esophageal squamous cell carcinoma patientsRyo Kato, Makoto Yamasaki, Shinya Urakawa, et al.
Blood|February 11, 2012
Cancer/testis antigens are novel targets of immunotherapy for adult T-cell leukemia/lymphomaHiroyoshi Nishikawa, Yuka Maeda, Takashi Ishida, et al.
Journal of Medicinal Chemistry|November 3, 2012
Rapid discovery of highly potent and selective inhibitors of histone deacetylase 8 using click chemistry to generate candidate librariesTakayoshi Suzuki, Yosuke Ota, Masaki Ri, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|July 31, 2003
Further investigation of the epitope recognized by the new monoclonal antibody 2C9Keitaro Kato, Kazuhiro Yoshikawa, Tomohiro Taki, et al.
Pageof 34